Afrikaners may be more likely to carry Angelina Jolie's breast cancer gene

A physician examines a mammogram.
A physician examines a mammogram.

Breast cancer is the most common cancer in South African women and will affect one in every 33 women in the country.

According to Stellenbosch University geneticist Prof Maritha Kotze, about 15 percent of all cancers including those affecting the breasts are inherited. Just two genes, known as BRCA1 and 2, are responsible for most hereditary breast cancers. 

In 2013, genetic testing revealed that Jolie carried the BRCA1 gene. Having recently lost her own mother to cancer, the star opted to have a preventative double mastectomy in an attempt to avoid developing breast cancer.

ReadAngelina's double mastectomy is the safest choice for some women

New research presented on Tuesday at the Cancer Association of South Africa’s (CANSA) Research in Action Conference in Stellenbosch has shown that these potentially killer genes may be more predominant among Afrikaner cancer patients. 

According to the research, 67 percent of Afrikaans breast cancer patients from high-risk families that were surveyed, were found to carry at least one of the genes. Meanwhile, BRCA-related cancers only accounted for eight percent of breast cancers among black women, according to Lizette Jansen van Rensburg, a professor in Genetics at the University of Pretoria.

According to the latest available data from the National Cancer Registry dating back to 2009, Asian women have the highest risk of developing breast cancer, closely followed by white and then coloured women. According to the data, black women have the lowest breast cancer risk. 

New research may also indicate that genes not only play an important role in whether a woman will develop breast cancer or not, but also impacts on what treatment will have the best outcome. This may open up the field of personalised treatment in South Africa.

Read: Your medical aid scheme and breast cancer

Kotze’s research has shown that cancers caused by different genes may respond differently to different types of therapy, making it possible to customize treatment for patients, based on advanced micro array technology and next-generation sequencing.

A web portal ( was developed with the support of the Medical Research Council to assist patients and doctors to identify genetic testing most likely to benefit patients’ treatment outcomes. 

“We strive towards one day providing each patient with a drug targeted specifically at their tumour’s genetics,” said Kotze. 

Read more:

New research on 'Angelina Jolie' breast cancer genes
Angelina Jolie inspires breast cancer risk assessment
Afrikaners at risk of Parkinson's
Afrikaner schizophrenia gene analysed

Image: x-ray of the breast, Shutterstock

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For 14 free days, you can have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today. Thereafter you will be billed R75 per month. You can cancel anytime and if you cancel within 14 days you won't be billed. 
Subscribe to News24
Voting Booth
The ANC's leadership race is heating up. Who do you think will be elected party president at Nasrec in December?
Please select an option Oops! Something went wrong, please try again later.
Nkosazana Dlamini-Zuma has got it in the bag
7% - 619 votes
I foresee a second term for Cyril Ramaphosa
83% - 7424 votes
Don’t discount a Zweli Mkhize win
10% - 923 votes
Rand - Dollar
Rand - Pound
Rand - Euro
Rand - Aus dollar
Rand - Yen
Brent Crude
Top 40
All Share
Resource 10
Industrial 25
Financial 15
All JSE data delayed by at least 15 minutes Iress logo
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.